Showing results (871-880 of 1,823) with videos related to

Sort By:
Pageof 183
Transplantation and Cellular Therapy|July 22, 2026
Acute Kidney Injury in Recipients of Chimeric Antigen Receptor T-Cell Therapy: Clinical Characteristics and Impact on MortalityHadeel Jazieh, Abedalrahman Almashayekh, J Curran Henson, et al.
Transplantation and Cellular Therapy|July 27, 2026
CAR-based cellular therapies for autoimmune diseases: immune reset, clinical evidence, and translational boundariesMiao Huang, Renjie Huang, Dongyan Wang
Transplantation and Cellular Therapy|July 30, 2026
Cis-targeted IL-2 mutein to augment the anti-tumor activity of engineered T cellsSara Sleiman, Nathan D Mathewson, Tyler Hansen, et al.
Transplantation and Cellular Therapy|August 1, 2026
Enumeration of CD34-CD133+ Haematopoietic Progenitor Cells in Cord BloodGuy Klamer, Kap-Hyoun Ko
Transplantation and Cellular Therapy|August 10, 2026
Insights to provider practice of germline testing for inherited hematologic malignancy predisposition syndromes to inform hematopoietic stem cell transplantationAllison S Williams, Anna DeSalvo, Gabriela Sanchez-Petitto, et al.
Transplantation and Cellular Therapy|August 4, 2026
Serum-Free Expanded Hair Follicle Mesenchymal Stem Cells Promote Cartilage Repair in a Murine Full-Thickness Defect ModelHaoChen Sun, Emilie Gysel, Leila Larijani, et al.
Transplantation and Cellular Therapy|August 7, 2026
Prognostic factors for early mortality following allogeneic hematopoietic cell transplantation in hematologic malignanciesEmily Wolf, Megan Melody, Athanasios Tsalatsanis, et al.
Transplantation and Cellular Therapy|August 15, 2026
Clinical relevance of TCI score-based refinement of conditioning intensity in cord blood transplantation for myelodysplastic syndromeMachiko Fujioka, Hidehiro Itonaga, Yasushi Miyazaki, et al.
Transplantation and Cellular Therapy|August 23, 2026
Reduced-Dose Post-Transplant Cyclophosphamide (PTCy 40-40) in Allogeneic Hematopoietic Cell TransplantationLauren Scarpetti, Qiuhong Zhao, Daniel Ikeda, et al.
Transplantation and Cellular Therapy|August 4, 2026
Body Mass Index and Outcomes after CD19 Chimeric Antigen Receptor T-Cell Therapy for Relapsed/Refractory B-Cell Lymphoma: A Nationwide Registry StudyTatsuya Konishi, Wataru Kitamura, Shohei Mizuno, et al.
Pageof 183